Ex­clu­sive: Nurse-hir­ing uni­corn In­cred­i­ble Health cuts work­ers

Last year
Health Tech

Ex-Pfiz­er staffer found guilty of in­sid­er trad­ing af­ter buy­ing stock op­tions a day be­fore Paxlovid da­ta re­veal

Last year
Law

Neu­ro­science leg­end Steve Paul re­tires; Ex­clu­sive: GSK hires ex-In­nate Phar­ma CEO for new po­si­tion

Last year
People
Peer Review

Re­turn of the SPAC? Bi­hua Chen and Cor­morant go for round two af­ter Moon­Lake suc­cess

Last year
Financing

Sen­a­tor ques­tions CVS, Wal­greens about growth in 340B par­tic­i­pa­tion

Last year
Pharma
Law

GSK sells par­tial stake of con­sumer health spin­off Ha­le­on for $1.2B

Last year
Pharma

Sen­ate health com­mit­tee to vote on rare sub­poe­nas for J&J and Mer­ck CEOs over drug pric­ing tes­ti­mo­ny

Last year
Pharma
Law

The Supreme Court could over­turn the Chevron doc­trine. Here’s how that could hurt the FDA

Last year
Pharma
FDA+

Sun Phar­ma to buy out the rest of Taro's own­er­ship

Last year
Deals
Pharma

J&J hosts celebri­ties and Blue Jack­et fash­ions dur­ing NY Fash­ion Week for prostate can­cer aware­ness

Last year
Pharma
Marketing

'Peo­ple want vanil­la ice cream': CEO Anne Wo­j­ci­c­ki grap­ples with 23and­Me's dual iden­ti­ty

Last year
People
Pharma

No­vo re­sumes We­govy 1.7 mg sup­ply; GSK’s £200M man­u­fac­tur­ing ex­pan­sion in the UK; Smart­Labs’ $48M Se­ries C

Last year
Manufacturing

Lutetium, ac­tini­um or lead: Can iso­tope type of­fer an edge in ra­dio­ther­a­py?

Last year
In Focus
Manufacturing

Bridge­Bio rais­es up to $1.2B, a month af­ter sub­mit­ting car­dio drug to FDA

Last year
Financing

Virid­i­an’s $150M of­fer­ing; Sur­rozen scraps IBD drug can­di­date; As­sem­bly ends deal with In­di­ana Uni­ver­si­ty

Last year
News Briefing

Tai­wan-based CD­MO Bo­ra Phar­ma to pay up to $210M for Up­sh­er-Smith to ex­pand in­to the US

Last year
Manufacturing

CG On­col­o­gy aims for $181M list­ing in first biotech IPO of 2024

Last year
Financing

Up­dat­ed: No­var­tis ax­es PhI­II peanut al­ler­gy tri­al, ex­pects to test 'op­ti­mized dos­ing' in new tri­al lat­er this year

Last year
R&D

Sat­suma's nasal mi­graine can­di­date re­ject­ed by FDA over CMC is­sues 

Last year
FDA+
Manufacturing

In­vest­ment firm Mi­rae launch­es its US biotech VC fund with $50M

Last year
Financing

Bay­er to make sig­nif­i­cant cuts, rolls out new mod­el at 'ex­pense of many man­age­r­i­al em­ploy­ees'

Last year
Pharma

EMD Serono lays out MS ther­a­pies' im­mune-sys­tem sup­pres­sion risks in new cam­paign

Last year
Pharma
Marketing

Pfiz­er and BioN­Tech urge US patent re­view board to take on Mod­er­na's Covid patents

Last year
Pharma
Coronavirus

Roche's TIG­IT win lim­it­ed by stan­dard of care change, lack of glob­al study

Last year
R&D
First page Previous page 215216217218219220221 Next page Last page
A service from the Financial Times